ArticleFrontiers in nutrition2025
ZJU index as a predictive biomarker of gestational diabetes mellitus: a prospective cohort analysis.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Exploring the oral microbiome diversity and genus signatures associated with a novel non-invasive metabolic indicator: a cross-sectional study.The Saudi dental journal · 2026Article
- ZJU index and the prevalence of kidney stones in US adults: evidence from NHANES 2007-2018.BMC urology · 2026Article
- Associations of the Zhejiang University (ZJU) index with reproductive outcomes in women with polyendocrine metabolic ovarian syndrome: aFrontiers in nutrition · 2026Article
- The association between the ZJU index and short-term prognosis in patients with acute ischemic stroke: a cohort study.Frontiers in endocrinology · 2026Article
- Association between the Zhejiang University index and hyperuricemia among adults with type 2 diabetes in China.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The ZJU index, incorporating fasting plasma glucose (FPG), lipid profiles, liver enzymes, and body mass index (BMI), serves as a multidimensional tool for assessing metabolic dysregulation. This prospective investigation examined first-trimester ZJU index associations with both gestational diabetes mellitus (GDM) risk and nonalcoholic fatty liver disease (NAFLD) during pregnancy, while simultaneously evaluating the relationships between lipid profiles, liver enzymes, and GDM development. Methods: We conducted analyses using multivariable logistic regression and restricted cubic splines (RCS) to assess associations of the ZJU index, liver enzymes, and blood lipids with GDM, as well as the association between the ZJU index and NAFLD. Subgroup analyses were conducted to evaluate the correlation between the ZJU index (stratified by age and reproductive history) and GDM. The receiver operating characteristic (ROC) curve assessed the ZJU index's predictive power. The robustness of the findings was verified via sensitivity analyses. Results: In the multivariable regression model, the ZJU index showed a significant positive association with GDM, after adjusting for confounders [OR = 1.22, 95% CI (1.13-1.32)]. The RCS analysis revealed a linear dose-response relationship between the ZJU index and GDM. The area under the curve (AUC) for the ZJU index was 0.802, indicating a high predictive ability for GDM. Associations between the ZJU index and GDM remained consistent across subgroups and sensitivity analyses. Conclusion: The ZJU index is closely associated with GDM prevalence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.